Identification ACTA2 and KDR as key proteins for prognosis of PD‐1/PD‐L1 blockade therapy in melanoma

Identification ACTA2 and KDR as key proteins for prognosis of PD‐1/PD‐L1 blockade therapy in melanoma

Abstract Programmed cell death protein 1 (PD‐1) /programmed cell death ligand 1 (PD‐L1) blockade is an important therapeutic strategy for melanoma, despite its low clinical response. It is important to identify genes and pathways that may reflect the clinical outcomes of this therapy in patients. We...

Full description

Bibliographic Details
Main Authors: Yuchen Wang, Zhaojun Li, Zhihui Zhang, Xiaoguang Chen
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Animal Models and Experimental Medicine
Subjects:
expression profiling data
hub genes
melanoma
PD‐1/PD‐L1 blockade therapy
Online Access:https://doi.org/10.1002/ame2.12154

Internet

https://doi.org/10.1002/ame2.12154

Similar Items